JW Shinyak Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JW Shinyak Corp with three other
companies in this sector in South Korea:
Dongsung Pharmaceutical Company Limited
sales of 91.91 billion Korean Won [US$80.79 million]
of which 85%
was Pharmaceutical Segment),
Wooridul Pharmaceutical Limited
(89.10 billion Korean Won [US$78.32 million]
of which 89%
was Finished Goods Revenues), and
Hanall Biopharma Company Limited
(91.84 billion Korean Won [US$80.73 million]
of which 58%
was Finished Goods).
JW Shinyak Corp reported sales of 91.78 billion Korean Won (US$80.67 million)
December of 2018.
increase of 19.4%
versus 2017, when the company's sales were 76.84 billion Korean Won.